Lung cancer is one of the leading causes of death all around the world and is especially rampant in India. It is a fear-inducing disease due to its debilitating, terminal consequences. In India, lung cancer has been one of the leading causes of cancer-related deaths for a long time. In fact, the Indian Council of Medical Research (ICMR) has estimated that it accounts for roughly one-sixth of all deaths due to cancer in the country.
Prevalence of this widespread disease
The exact reason for the high prevalence of the disease in India is not definitively known, but experts have cited factors such as air pollution, the use of tobacco products, and industrial hazardous materials being thrown into the environment as some of the strongest suspects. With air pollution being especially severe in many of the bigger cities, this has also led to an increased risk of lung cancer amongst the Indian population. Furthermore, India is also one of the biggest exporters of tobacco products in the world, which indirectly affects the population's overall health and increases the chances of people developing the devastating disease.
The initiative from governments and organizations worldwide
Though the numbers are relatively better compared to the rest of the world, they are still causing concern. As a result, many organizations and governmental bodies have taken measures to tackle lung cancer in India by raising awareness and educating people about the risks and side effects of using these harmful products. Organizations such as IGCS (International Germ Cell Symposium), The Indian Cancer Society, and FORCE (Foundation for Research on Carcinogenesis and Chemoprevention) are just some of the many organizations that are actively playing their part in this cause.
In addition to that, the Government of India has also taken steps to minimize the prevalence of lung cancer in the country by trying to minimize air pollution, banning harmful tobacco products, and providing free treatment to people in need. Despite all these government and non-governmental interventions, the number of cases of lung cancer in India still remains high. Therefore, it is important that we all become more aware of the risks associated with the disease and work together to help curb its prevalence.
Treatment as a cure
Gefitinib 250mg Tablet is a prescription medication used to treat non-small-cell lung cancer (NSCLC). It belongs to a class of medications known as tyrosine kinase inhibitors. It works by blocking tyrosine kinase enzymes, which are substances in the body responsible for the growth, spread, and proliferation of cancer cells. Gefitinib 250mg Tablet uses to decrease the growth of cancer cells and can help improve overall survival.
Dose of administration
Gefitinib 250mg Tablet is typically administered orally, once daily. It is usually taken on an empty stomach at least one hour before a meal or two hours after a meal. The tablets should be swallowed whole and should not be crushed or chewed. If a dose is missed, it should not be taken in the evening or near bedtime to prevent problems sleeping.
Effects as a possible precaution
Gefitinib 250mg Tablet is generally well-tolerated but side effects can occur in some individuals. Side effects can range from mild to severe and can include fatigue, diarrhea, nausea, rash, and headache. Other rare but serious side effects may include liver problems, heart and lung problems, skin infection, bone marrow suppression, and vision or hearing problems.
Talk to your doctor or healthcare professional
Before taking Gefitinib 250mg Tablet, it is important to talk to your doctor about any medical conditions you have, any other medications or supplements you take, and any potential drug interactions that may be present. Other important things to consider include allergies, age, and kidney or liver impairment. Pregnant or breastfeeding women should also discuss any possible risks with their doctor.
Discuss before taking this dosage
Gefitinib 250mg Tablet is generally well-tolerated when taken as prescribed. However, side effects can occur. All potential risks and side effects should be discussed with a doctor before taking Gefitinib 250mg Tablet. With regular use and appropriate follow-up, Gefitero 250mg Tablet can help increase overall survival in people with non-small-cell lung cancer.
Conclusion
Overall, it can be seen that the status of lung cancer in India is particularly alarming and is a pressing public health concern. It is high time that all of us come together and work collectively to tackle this problem before it is too late.
Comments
Post a Comment